News
An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...
Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...
2h
The Independent on MSNRSV jab in pregnancy can ‘significantly’ cut baby’s infection risk, study saysRSV jab in pregnancy can ‘significantly’ cut baby’s infection risk, study says - Vaccinating pregnant women against RSV will ‘significantly’ reduce the risk their babies being hospitalised ...
Premature babies in the UK can now be protected against RSV with a single, long-lasting injection available on the NHS for ...
The new injection, Nirsevimab, will be given to high-risk babies, including those born too early to be protected by the RSV ...
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
Explore more
A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...
Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...
The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results